MGX (Metagenomi Therapeutics) OCF Margin %: -1,696.71% (As of Mar. 2026)


MGX Metagenomi Therapeutics Inc MGX
10 GF Score
Price $1.19
! 4 Warning Signs
View Full Analysis

What is Metagenomi Therapeutics OCF Margin %?

Metagenomi Therapeutics MGX -1.08% 10 OCF Margin % is -1,696.71% as of Mar. 2026. GuruFocus rates MGX with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 960 Biotechnology companies, Metagenomi Therapeutics ranks worse than 69.79% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Metagenomi Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-21.18 Mil. Metagenomi Therapeutics's Revenue for the three months ended in Mar. 2026 was $1.25 Mil. Therefore, Metagenomi Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was -1,696.71%.

As of today, Metagenomi Therapeutics's current OCF Yield % is -194.70%.

The historical rank and industry rank for Metagenomi Therapeutics's OCF Margin % or its related term are showing as below:

MGX' s OCF Margin % Range Over the Past 10 Years
Min: -352.61   Med: -204.24   Max: 9982.3
Current: -390.6

During the past 5 years, the highest OCF Margin % of Metagenomi Therapeutics was 9982.30%. The lowest was -352.61%. And the median was -204.24%.

MGX's OCF Margin % is ranked worse than
69.79% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs MGX: -390.60

Metagenomi Therapeutics OCF Margin % Related Terms

Metagenomi Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Metagenomi Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metagenomi Therapeutics OCF Margin % Chart

Metagenomi Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
9,982.30 172.81 -204.24 -208.57 -352.61

Metagenomi Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -553.48 -249.63 -245.44 -602.05 -1,696.71

MGX vs HYPD, ATYR, ACTU: OCF Margin % Comparison

For the Biotechnology subindustry, Metagenomi Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metagenomi Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metagenomi Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Metagenomi Therapeutics's OCF Margin % falls into.


MGX
10GF Score
Metagenomi Therapeutics Inc MGX
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metagenomi Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Metagenomi Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-88.892/25.21
=-352.61 %

Metagenomi Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-21.175/1.248
=-1,696.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1,696.71% mean?
Metagenomi Therapeutics (MGX) has a OCF Margin % of -1,696.71% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Metagenomi Therapeutics and its competitors. According to the industry distribution chart, Metagenomi Therapeutics ranks #670 out of 960 companies in the Biotechnology industry, placing it in the top 69.8%.
Is Metagenomi Therapeutics' OCF Margin % too high?
Metagenomi Therapeutics' current OCF Margin % is -1,696.71%. Based on the distribution chart, Metagenomi Therapeutics ranks #670 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Metagenomi Therapeutics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Metagenomi Therapeutics' OCF Margin % compare to HYPD and ATYR?
According to the Biotechnology industry distribution chart, Metagenomi Therapeutics ranks #670 out of 960 companies for OCF Margin %. This places Metagenomi Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Metagenomi Therapeutics and its competitors. Metagenomi Therapeutics's current OCF Margin % is -1,696.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metagenomi Therapeutics stock overvalued right now?
Metagenomi Therapeutics (MGX) has a current OCF Margin % of -1,696.71%. The current OCF Margin % is -1,696.71%. Metagenomi Therapeutics' overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Metagenomi Therapeutics (MGX), the current OCF Margin % is -1,696.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metagenomi Therapeutics Business Description

Address 5959 Horton Street, 7th Floor, Emeryville, CA, USA, 94608
Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.
10GF Score

Get the complete analysis for MGX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price